# US 2024/0197602 A1 · Dermatological topical agent composition containing useful component-including taurine crystals

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197602 A1
- Document ID: US20240197602A1
- Status: Published application
- Kind: A1
- Application number: 18/565,074
- Filed: 2022-12-21
- Published: 2024-06-20
- Earliest claimed: 2022-04-25
- Assignees: Cosmed Pharmaceutical Co., Ltd.
- Applicants: Cosmed Pharmaceutical Co., Ltd.
- Inventors: Tomohiro Murayama; Hiroshi Tanaka; Junya Hasegawa; Ying-shu Quan; Fumio Kamiyama
- Web page: https://patentgrep.com/patent/US20240197602A1

## CPC

- A61K 8/466: {containing sulfonic acid derivatives; Salts}
- A61K 8/02: characterised by special physical form
- A61K 8/0245: {Specific shapes or structures not provided for by any of the groups of A61K8/0241}
- A61K 8/34: Alcohols
- A61K 8/35: Ketones, e.g. benzophenone
- A61K 8/44: Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K 8/46: containing sulfur (A61K8/44 takes precedence)
- A61K 8/4926: {having six membered rings}
- A61K 8/4946: {Imidazoles or their condensed derivatives, e.g. benzimidazoles}
- A61K 8/58: containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K 8/60: Sugars; Derivatives thereof
- A61K 8/602: {Glycosides, e.g. rutin}
- A61K 8/604: {Alkylpolyglycosides; Derivatives thereof, e.g. esters}
- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61K 8/67: Vitamins
- A61K 8/673: {Vitamin B group}
- A61K 8/675: {Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde (tocopheryl nicotinate A61K8/678)}
- A61K 8/97: from algae, fungi, lichens or plants; from derivatives thereof
- A61K 31/185: Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids (hydroxamic acids A61K31/16; peroxy acids A61K31/327)
- A61K 45/00: Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61P 17/16: Emollients or protectives, e.g. against radiation
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61Q 1/00: Make-up preparations; Body powders; Preparations for removing make-up
- A61Q 17/005: {Antimicrobial preparations}
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/007: {Preparations for dry skin}
- A61Q 19/02: for chemically bleaching or whitening the skin
- A61Q 19/08: Anti-ageing preparations
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

A new means of intradermal delivery of a useful component is provided. Disclosed are an external-use skin preparation composition comprising fine needlelike taurine crystals including a useful component in the crystals, and a method for producing a fine needlelike taurine crystal including a useful component in the crystal, the method comprising a step of growing a crystal in an environment in which an aqueous solution (A) containing taurine dissolved is mixed with or held in contact with a liquid substance (B) having low solubility of taurine, wherein the useful component is dissolved or dispersed in the aqueous solution (A) or the liquid substance (B), whereby the useful component is included in the crystal along with the growth of the crystal.

## Claims

### Claim 1

An external-use skin preparation composition comprising fine needlelike taurine crystals including a useful component in the crystals.

### Claim 2 (depends on 1)

The external-use skin preparation composition according to claim 1, wherein the fine needlelike taurine crystals are contained with at least a part thereof dispersed.

### Claim 3 (depends on 1)

The external-use skin preparation composition according to claim 1, wherein each of the fine needlelike taurine crystals contains a space, and a useful component is enclosed in the space.

### Claim 4 (depends on 3)

The external-use skin preparation composition according to claim 3, wherein a space volume in the fine needlelike taurine crystal accounts for 0.0010% to 30% of a volume of the taurine crystal.

### Claim 5 (depends on 1)

The external-use skin preparation composition according to claim 1, wherein the fine needlelike taurine crystals have a thickness of 150 micrometers or less and a length of 3000 micrometers or less.

### Claim 6 (depends on 1)

The external-use skin preparation composition according to claim 1, wherein the useful component is one or two or more selected from the group consisting of vitamins and vitamin derivatives, hydroquinone and derivatives thereof, whitening components, anti-inflammatory components, antioxidant components, blood circulation promoting components, cell activating components, coenzymes and intermediate metabolites thereof, saccharides, plant extraction components, peptides, proteins, and dyes.

### Claim 7 (depends on 1)

The external-use skin preparation composition according to claim 1, wherein an inclusion ratio of the useful component in the fine needlelike taurine crystals is 0.001% to 30%.

### Claim 8 (depends on 1)

The external-use skin preparation composition according to claim 1, wherein the useful component is also dissolved or dispersed in an external-use skin preparation composition medium.

### Claim 9

A method for producing a fine needlelike taurine crystal including a useful component in the crystal, the method comprising a step of growing a crystal in an environment in which an aqueous solution (A) containing taurine dissolved is mixed with or held in contact with a liquid substance (B) having low solubility of taurine, wherein the useful component is dissolved or dispersed in the aqueous solution (A) or the liquid substance (B), whereby the useful component is included in the crystal along with the growth of the crystal.

### Claim 10 (depends on 9)

The production method according to claim 9, wherein the liquid substance (B) is a water-soluble organic solvent.

### Claim 11 (depends on 10)

The production method according to claim 10, wherein the water-soluble organic solvent is one or two or more selected from the group consisting of ethanol, isopropyl alcohol, ethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, isoprene glycol, diethylene glycol, dipropylene glycol, glycerin, diglycerin, 1,2-pentanediol, 1,2-hexanediol, cyclohexylglycerin, and n-hexylglycerin.

### Claim 12 (depends on 9)

The production method according to claim 9, wherein a concentration of the useful component is 0.001% by mass or more in the aqueous solution (A) or the liquid substance (B).

### Claim 13 (depends on 9)

The production method according to claim 9, wherein a concentration of taurine in the aqueous solution (A) is 3 to 28% by mass.

### Claim 14 (depends on 9)

The production method according to claim 9, wherein the liquid substance (B) accounts for 50% by mass or less with respect to the entire amount of the aqueous solution (A).

### Claim 15

A method for producing an external-use skin preparation composition comprising a fine needlelike taurine crystal including a useful component in the crystal, the method comprising the following steps:
a step of growing a crystal in an environment in which an aqueous solution (A) containing taurine dissolved is mixed with or held into contact with a liquid substance (B) having low solubility of taurine, wherein a useful component is dissolved or dispersed in the aqueous solution (A) or the liquid substance (B), whereby the useful component is included in the crystal along with the growth of the crystal; and
blending the fine needlelike taurine crystal including the useful component in the crystal, which is obtained in the step of growing a crystal, into an external-use skin preparation composition.

### Claim 16 (depends on 15)

The production method according to claim 15, wherein a concentration of the useful component is 0.001% by mass or more in the aqueous solution (A) or the liquid substance (B).

### Claim 17 (depends on 15)

The production method according to claim 15, wherein a concentration of taurine in the aqueous solution (A) is 3 to 28% by mass.

### Claim 18 (depends on 15)

The production method according to claim 15, wherein the liquid substance (B) accounts for 50% by mass or less with respect to the entire amount of the aqueous solution (A).

### Claim 19 (depends on 15)

The production method according to claim 15,
wherein the liquid substance (B) is a water-soluble organic solvent, and
the water-soluble organic solvent is one or two or more selected from the group consisting of ethanol, isopropyl alcohol, ethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, isoprene glycol, diethylene glycol, dipropylene glycol, glycerin, diglycerin, 1,2-pentanediol, 1,2-hexanediol, cyclohexylglycerin, and n-hexylglycerin.
